Cocrystallization of nonsteroidal anti-inflammatory drug fenamates (<i>N</i>-phenylanthranilic acid (N-PA), niflumic acid0 (NFA), flufenamic acid (FFA), tolfenamic (TFA) and mefenamic acids (MFA)) with 4,4′-bipyridine (BP) has resulted in the formation of cocrystals with a 2:1 molar ratio. Crystal Packing Similarity analysis has revealed that the packing arrangement of the [N-PA+BP], [TFA+BP], and [MFA+BP] cocrystals consists of discrete fragments of the crystal structures of initial APIs connected to each other by BP molecules. In the case of [FFA+BP], the cocrystal contains a previously unseen packing arrangement of FFA molecules which may be a fragment of a new polymorphic FFA form. Differential scanning calorimetry studies show a good c...
International audienceMorniflumate diniflumate, a molecular compound involving niflumic acid and its...
Crystal habit modification of the drug diflunisal that normally grows into extremely thin, long need...
Morniflumate diniflumate, a molecular compound involving niflumic acid and its ß-morpholino ethyl es...
Cocrystallization of nonsteroidal anti-inflammatory drug fenamates (<i>N</i>-phenylanthranilic acid ...
Cocrystal formation between nicotinamide and five fenamic acid derivative drugs (flufenamic acid, ni...
Pharmaceutical cocrystals of nonsteroidal anti-inflammatory drugs diflunisal (DIF) and diclofenac (D...
This work reports two novel drug–drug cocrystals of antifungal clotrimazole (CLT) with nonsteroidal ...
Furosemide (FS), a loop diuretic drug commonly used for the treatment of hypertension and edema, exh...
The work presented in this dissertation focuses on the molecular features of small molecules and the...
Altres ajuts: Fundació La Caixa: CB615921; CB616406; UAB: programa de beques PIF predoctoralsThe rea...
In this paper, we report the crystal growth of four cocrystals of furosemide (4-chloro-2-[(2-furanyl...
Abstract The selection of the crystalline phases in a form of molecular cocrystals has become scient...
In this paper, we report the crystal growth of four cocrystals of furosemide (4-chloro-2-[(2-furanyl...
International audienceMorniflumate diniflumate, a molecular compound involving niflumic acid and its...
Crystal habit modification of the drug diflunisal that normally grows into extremely thin, long need...
Morniflumate diniflumate, a molecular compound involving niflumic acid and its ß-morpholino ethyl es...
Cocrystallization of nonsteroidal anti-inflammatory drug fenamates (<i>N</i>-phenylanthranilic acid ...
Cocrystal formation between nicotinamide and five fenamic acid derivative drugs (flufenamic acid, ni...
Pharmaceutical cocrystals of nonsteroidal anti-inflammatory drugs diflunisal (DIF) and diclofenac (D...
This work reports two novel drug–drug cocrystals of antifungal clotrimazole (CLT) with nonsteroidal ...
Furosemide (FS), a loop diuretic drug commonly used for the treatment of hypertension and edema, exh...
The work presented in this dissertation focuses on the molecular features of small molecules and the...
Altres ajuts: Fundació La Caixa: CB615921; CB616406; UAB: programa de beques PIF predoctoralsThe rea...
In this paper, we report the crystal growth of four cocrystals of furosemide (4-chloro-2-[(2-furanyl...
Abstract The selection of the crystalline phases in a form of molecular cocrystals has become scient...
In this paper, we report the crystal growth of four cocrystals of furosemide (4-chloro-2-[(2-furanyl...
International audienceMorniflumate diniflumate, a molecular compound involving niflumic acid and its...
Crystal habit modification of the drug diflunisal that normally grows into extremely thin, long need...
Morniflumate diniflumate, a molecular compound involving niflumic acid and its ß-morpholino ethyl es...